Hengehold Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Buy
823
+5
+0.6% +$2.4K 0.03% 153
2026
Q1
$402K Sell
818
-112
-12% -$60.8K 0.04% 146
2025
Q4
$539K Sell
930
-226
-20% -$128K 0.05% 134
2025
Q3
$561K Buy
1,156
+42
+4% +$19.5K 0.05% 131
2025
Q2
$452K Buy
1,114
+14
+1% +$5.85K 0.04% 139
2025
Q1
$547K Buy
1,100
+461
+72% +$250K 0.05% 119
2024
Q4
$332K Buy
639
+115
+22% +$63.2K 0.03% 162
2024
Q3
$324K Buy
524
+124
+31% +$73.4K 0.03% 151
2024
Q2
$221K Buy
+400
New +$229K 0.02% 179

Other funds holding TMO

Hengehold Capital Management's TMO Position: Q2 2026 in Review

Hengehold Capital Management increased its Thermo Fisher Scientific (TMO) stake by 0.61% in Q2 2026, buying an estimated $2.4K and bringing the position to 823 shares worth $413K. The position accounts for 0.03% of the portfolio, ranked #153.

Hengehold Capital Management first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. The position peaked at $561K in Q3 2025. 1,659 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Hengehold Capital Management held 823 shares of Thermo Fisher Scientific worth $413K as of Q2 2026.
  • Hengehold Capital Management bought 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.03% of Hengehold Capital Management's portfolio in Q2 2026, its #153 holding.
  • Hengehold Capital Management first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
  • Hengehold Capital Management's Thermo Fisher Scientific position peaked at $561K in Q3 2025.
  • 1,659 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.